Sales in the extended release drugs market are expected to rise at a CAGR of 11% over the forecast period 2022-2032. Extended release drugs market is currently valued at US$ 48 Bn. Due to changes in the prescription patterns and rising acceptance of diverse dosage forms, demand for extended release drugs is anticipated to bolster in the forthcoming years. Request Sample@ …
Continue reading “Extended Release Drugs Expanding R&D Projects to Drive Market Growth”